Stock 9926 AKESO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Akeso, Inc.

Equities

9926

KYG0146B1032

Delayed Hong Kong S.E.
Other stock markets
 08:08:30 29/04/2024 am IST 		5-day change 1st Jan Change
49.25 HKD +1.13% Intraday chart for Akeso, Inc. +11.16% +6.25%
24/04 Akeso’s Supplemental New Drug Application for Cervical Cancer Drug Accepted by Chinese Regulator MT
24/04 National Medical Products Administration Accepted the Supplemental New Drug Application by Akeso, Inc. for (Cadonilimab, Pd-1/Ctla-4) as First-Line Treatment for Cervical Cancer CI

Evolution of the average Target Price on Akeso, Inc.

Price target over the last 5 years

History of analyst recommendation changes

134ad7df4da465a8aabe9270.V-JzfmBLxEl1VwDeGifjSsnPgeI9fukTwaltsY9D5lA.Ga8hTycHtSQACDm3T2CXLp3-6LoINYVqm9lUguIzhxsHjBoQVie2ICIDaw~2a5e790920420cc718edb33ca928a62a

Analyst Recommendations on Akeso, Inc.

Nomura Adjusts Akeso’s Price Target to HK$52.80 From HK$48.84, Keeps at Buy MT
Nomura Adjusts Akeso's Price Target to HK$48.84 From HK$50.14, Keeps at Buy MT
Nomura Adjusts Akeso's Price Target to HK$50.14 From HK$46.04, Keeps at Buy MT
Nomura Adjusts Akeso's Price Target to HK$46.04 From HK$31.54, Keeps at Buy MT
Nomura Adjusts Akeso's Price Target to HK$31.54 From HK$35.81, Keeps at Buy MT
UBS Adjusts Akeso’s Price Target to HK$26.68 From HK$29.60, Keeps at Buy MT
UBS Adjusts Akeso’s Price Target to HK$29.60 From HK$32.40, Keeps at Buy MT
Nomura Adjusts Akeso's Price Target to HK$35.81 From HK$53.66, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
45.08 CNY
Average target price
55.44 CNY
Spread / Average Target
+22.97%
High Price Target
63.52 CNY
Spread / Highest target
+40.92%
Low Price Target
45.74 CNY
Spread / Lowest Target
+1.46%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Akeso, Inc.

Nomura
UBS

Ratings for Akeso, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 9926 Stock
  4. Consensus Akeso, Inc.